Canfite earnings
WebEdit. Can Fite Biofarma Ltd is an advanced clinical stage drug development company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, liver, and inflammatory disease. The company's lead drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis. WebJul 26, 2024 · CanFite Biopharma Ltd (CANF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Canfite earnings
Did you know?
WebMar 5, 2024 · Earnings Estimate Revisions for CanFite Biopharma Ltd For the fiscal year ending December 2024, this company is expected to earn -$1.26 per share, which is a … WebApr 6, 2024 · A high-level overview of Can-Fite BioPharma Ltd. (CANF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and …
WebFind real-time CANF - Can Fite Biopharma Ltd stock quotes, company profile, news and forecasts from CNN Business. WebIn fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns …
WebMar 30, 2024 · Can-Fite Biopharma Ltd ADR (CANF) reported a 4th Quarter December 2024 loss of $1.11 per share on revenue of $0.2 million. The consensus estimate was a … WebFor their last quarter, CanFite Biopharma (CANF) reported earnings of -$0.90 per share, beating the Zacks Consensus Estimate of $-1.00 per share. This reflects a positive earnings surprise of 10.00%.
WebCan-Fite Biopharma Ltd. ADR analyst ratings, historical stock prices, earnings estimates & actuals. CANF updated stock price target summary.
WebApr 6, 2024 · Can-Fite BioPharma Ltd. (CANF) latest earnings report: revenue, EPS, surprise, history, news and analysis. north lanarkshire planning phone numberWebCan Fite is trading at 3.24 as of the 14th of February 2024. This is a -6.36 percent decrease since the beginning of the trading day. The stock's lowest day price was 3.0. Stay informed regarding Can Fite Stock and understand the value of trading Can Fite now. Get the latest Can Fite detailed stock quotes, stock trade data, stock price info, and performance … north lanarkshire nhs complaintsWebWho invested in CanFite BioPharma? CanFite BioPharma has 5 investors including Cybele Holdings and Cybele Holdings. How much funding has CanFite BioPharma raised to date? CanFite BioPharma has raised $80.4M. When was the last funding round for CanFite BioPharma? CanFite BioPharma closed its last funding round on Aug 12, … north lanarkshire nhs jobsWebNext Earnings Date: The next reported earnings date. Stocks whose Next Earnings Date falls within the next 7 days are highlighted in red. Annual Dividend & Yield: The indicated annual dividend rate and yield, calculated from the latest dividend. The dividend rate is the portion of a company's profit paid to shareholders, quoted as the dollar ... north lanarkshire online planningWebMar 30, 2024 · Can-Fite BioPharma Ltd. reported earnings results for the full year ended December 31, 2024. For the full year, the company reported sales was USD 0.81 million compared to USD 0.853 million a year ago. Net loss was USD 10.17 million compared to USD 12.62 million a year ago. how to say neoadjuvantWebApr 7, 2024 · First quarter 2024 earnings released: US$0.004 loss per share (vs US$0.025 loss in 1Q 2024) May 28. No longer forecast to breakeven May 28. Can-Fite BioPharma … how to say neithWeb2 days ago · CanFite Biopharma Ltd (CANF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). 9 … how to say neither